# Safety, Tolerability and Efficacy of Nefopam Cream in Burn Patients

> **NCT04685577** · PHASE2 · COMPLETED · sponsor: **University of Alberta** · enrollment: 50 (actual)

## Conditions studied

- Burn; Multiple Body Regions, Max. Second Degree
- Third-Degree Burn
- Burn Degree Second

## Interventions

- **DRUG:** Nefopam
- **OTHER:** Placebo (Vehicle)

## Key facts

- **NCT ID:** NCT04685577
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-10
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04685577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04685577, "Safety, Tolerability and Efficacy of Nefopam Cream in Burn Patients". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT04685577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*